Items Tagged ‘heart disease’
August 10, 2021
Mayo Clinic Research in the news — 8/9/2021
By Advancing the Science contributor 
COVID-19 has once again taken almost all the headlines. However, research and expertise across the vastness of medicine still continues. Those stories are at the top — dancing after menopause, hemp seeds for inflammation, ‘brain orgasms’, and more. Then read on for the latest understanding in why the delta variant spreads even among vaccinated people, […]
Tags: Abinash Virk, Ala Dababneh, Angela Dispenzieri, antibodies, arthritis, Arya Mohabbat, cancer, cardiology, chemotherapy, COVID-19, dementia, Devang Sanghavi
July 26, 2021
Mayo Clinic Research in the news — 7/26/2021
By Advancing the Science contributor
Mayo Clinic expertise has a consistent footprint in the news in 2021. This week’s topics include data security and interoperability; some lesser discussed COVID-19 related topics: language development, booster vaccines for immunocompromised individuals, portable air filters; as well as early onset dementia, and the need for diversity among bone marrow donors. Vaccines are highy unlikely […]
Tags: Aaron Krych, acute kidney injury, Ahmad Nassr, antibodies, arthritis, artificial intelligence, big data, biomarkers, bone marrow transplant, Brian Weinshenker, Bruce Johnson, Bruce Sutor
July 12, 2021
Demystifying healing potential of stem cells
Mayo Clinic research has discovered proteins secreted by human stem cells that act as a “magic potion” to drive healing after a heart attack. The research uncovered that these cell-released regenerative particles harbor a pattern of functions mirrored in repair of the diseased heart, linking stem cell-transmitted information to the beneficial response of the recipient […]
Tags: Andre Terzic, cardiopoietic stem cells, Center for Regenerative Medicine, heart attack, heart disease, heart failure, Kent Arrell, stem cell therapy
May 10, 2021
Mayo Clinic Research in the news — 5/10/2021
Some Mayo Clinic research in the news this week is at the discovery level, in our genes. And at the other end of the research spectrum, better outcomes in a clinical setting — in this case, a new way to heal scars. Read the post for quick stops all along the continuum, including trauma, COVID-19, […]
Tags: Alzheimer's disease, artificial intelligence, big data, brain, Brian Kim, cancer prevention, cancer screening, Chyke Doubeni, clinical trials, colorectal cancer, data science, dementia
February 8, 2021
Mayo Clinic Research in the news — 2/8/2021
In the week’s news, you can find expertise from Mayo Clinic clinicians and researchers on a range of topics, including several different heart conditions, a blood test for Alzheimer’s, cancer, disparities in diabetes care, and of course COVID-19. Expertise from a Mayo Clinic International consultant is also highlighted, along with Michael Camilleri, M.D., who received […]
Tags: Alzheimer's disease, artificial intelligence, Bart Demaerschalk, blood cancer, blood disease, blood test, breast cancer, cardiology, cardiovascular disease, caregivers, Center for Digital Health, Center for the Science of Health Care Delivery
February 3, 2021
Diabetes Powerfully Associated with Premature Coronary Heart Disease in Women
By Advancing the Science contributor
A new biomarker of insulin resistance was tied to a 600 percent increase in risk of premature coronary heart disease By Brigham and Women’s Hospital Press Office BOSTON — While deaths related to heart disease have declined among older people, studies suggest that death rates among younger patients have remained stagnant or increased slightly. To […]
Tags: collaboration, coronary artery disease, diabetes, heart disease, Sagar Dugani, team science
February 2, 2021
Diabetes treatment disparities widespread, room for improvement
More than 34 million people in the U.S. have diabetes, reports the Centers for Disease Control and Prevention. Of these, the vast majority have type 2, or a reduced ability of their bodies to effectively process sugar in foods into energy for life. Most people with type 2 diabetes have multiple considerations – including heart […]
Tags: Centers for Disease Control and Prevention, diabetes, health care value, health disparities, health equity, heart disease, hypoglycemia, kidney disease, medication management, OptumLabs, pharmacy, Rozalina McCoy
January 25, 2021
Mayo Clinic Research in the news — 1/25/2021
From acupuncture, breast cancer, diabetes, euthyroid … all the way to Zika, Mayo Clinic research and experts are featured in the news. Also find COVID-19 observations, advice and findings. The Rochester Epidemiology Project: “The greatest medical resource you’ve never heard of” Rochester Magazine, 1/22/2021 The Rochester Epidemiology Project has changed the way we view ADHD. […]
Tags: acupuncture, acute flaccid myelitis, ADHD, Alzheimer's disease, amyloidosis, artificial intelligence, biomarkers, breast cancer, Brent Bauer, cancer, cancer genomics, cannabidiol (CBD)
December 31, 2020
Mayo Clinic Research in the news — 12/31/2020
Following are headlines and story excerpts highlighting Mayo Clinic Research and research faculty the last part of December 2020. Read on for advancements and information on esophageal cancer, antibiotic risks for babies and toddlers, a Mayo inductee into the Fellows of the National Academy of Inventors, and several other stories, including a slew of COVID-19 […]
Tags: antibiotic, Barrett's esophagus, breast cancer, clinical trials, Destination Medical Center, epidemiology, esophageal cancer, heart disease, hereditary cancer, Katherine Zeratsky, Matthew Goetz, News of the Week
December 21, 2020
Mayo Clinic Research in the news — 12/21/2020
Mid-December, many people are focused on activities and information related to the holidays. The news media are no exception, with very little attention paid to health care research, unless it has a holiday hook. As a result, news is slim about various advancements in understanding, treating and preventing disease. Nonetheless, Mayo Clinic Research and researchers […]
Tags: ADHD, antibodies, artificial intelligence, Barrett's esophagus, Brian Lacy, cancer, cardiovascular disease, clinical trials, COVID-19, data science, epidemiology, esophageal cancer